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INVITED COMMENTARY
Joseph L. Mills, MD, Tucson, Ariz
The Greenville group has addressed an important issue con-
cerning patients with critical limb ischemia (CLI). All would agree
that, when possible, ambulatory and functional patients with CLI
should undergo revascularization for limb salvage and that de-
mented, nonambulatory, nursing home–confined patients with
fixed contractures should undergo primary major limb amputa-
tion. An increasingly common problem is what to do with the frail
patient who fits somewhere in the middle of these two extremes of
the CLI patient spectrum. Many practices have moved toward
endoluminal therapy for such patients, on the basis of the yet-
unproven but logical premise that percutaneous therapy, although
less durable, may be less morbid and still permit limb salvage for
patients with limited life expectancies without incurring excessive
risk.
The authors conclude, on the basis of their nonrandomized,
retrospective study, that CLI patients who appear “physiologically
unsuitable for surgery have a very modest functional advantage
after treatment with PTA [percutaneous transluminal angioplasty]
compared to patients undergoing primary amputation” and that
“PTA should not be routinely employed for patients with CLI who
are medically and physiologically unsuitable for bypass.” Although
this is partially correct, I believe that the authors overstate their
case and fail to consider important factors needed to make a
decision in such patients.
The authors actually report that “there was a statistically
significant advantage in maintenance of ambulatory status for
patients undergoing PTA when compared to patients undergoing
primary amputation (60.2% versus 44% at 24 months, P .001).”
PTA patients also exhibited a significant advantage in maintenance
of independent living status at 2 years (60.5% vs 52.6%; P .046)
and lower rates of ambulatory failure (P .002) and lower rates of
living status deterioration (P  .025) than primary amputees. An
alternative interpretation of the authors’ own data, then, would be
that for whatever time frail CLI patients have left in the world, PTA
is in fact beneficial with respect to maintenance of ambulatory and
independent living status but that in such patients who actually live
more than 2 to 3 years, the benefits wane. The cost of PTA in these
patients was an apparently increased mortality compared with
primary amputation, but the two groups were not randomized and
differed in several important respects (table 1). Lack of random-
ization resulted in major differences between the PTA and primary
amputation groups; the most important difference was that nearly
twice as many amputation patients (56.3%) as PTA patients
(29.8%) had undergone previous vascular reconstruction (P 
.0001). The obvious inference is that the majority of patients in the
primary amputation group had already failed reasonable revascu-
larization attempts (and also survived those attempts), whereas the
PTA group more likely included the truly physiologically and
functionally impaired and not just those with “anatomic impair-
ment” (no conduit, no outflow, and so on). The 4.4% mortality
rate for amputees is also much lower than expected mortality rates
for major limb amputation in high-risk patients and leads one to
question their degree of physiologic impairment.
What factors need further study? First, the patients should
have been stratified both by Trans-Atlantic Inter-Society Consen-
sus (TASC) classification and degree of ischemia. TASC classifica-
tions for aortoiliac and infrainguinal disease are clear-cut, and one
would expect interventions for proximal and A/B lesions to be
simpler and more durable than more distal or complex (C/D)
interventions. Certainly the authors would not deny a frail patient
presenting with a small, nonhealing toe ulcer an iliac angioplasty
and stent for a 90% TASC A lesion. However, for an unsuitable
surgical candidate with complex infection extending into the fore-
foot and multilevel TASC C/D disease, primary amputation may
be the better part of valor. The authors did not report how many
subsequent foot debridements and local amputations were re-
quired to achieve limb salvage. This factor—repeated infections
and debridements after successful PTA—may have been the straw
that broke the camel’s back, and not the PTA itself. Such consid-
erations may have contributed to the reported 3-year survival of
only 18% in PTA patients compared with 33% in primary amputees.
Unfortunately, CLI is somewhat of a black hole; we still lack clear
definitions of degree of ischemia (trivial nonhealing toe ulcer,
simple toe gangrene, extensive forefoot necrosis, heel necrosis,
osteomyelitis, and so on), and the authors admittedly provided no
clinical information concerning the patients’ presentation. With-
out examining each patient to assess the degree of difficulty of
proposed limb-salvage efforts, it is impossible to interpret the data
in a meaningful way.
The authors have appropriately recognized that treatment of
the frail patient with CLI who is not believed to be an open-
surgical candidate is complex; injudicious PTA and multiple ag-
gressive foot debridements to effect limb salvage attempts at all
costs are unwarranted. However, we still do not have enough data
to deny all such patients revascularization. The issues facing the
vascular surgeon are nearly insurmountable and will likely always
require careful clinical judgment and individualized care. In addi-
tion to the numerous physiological, psychological, and social fac-
tors that require consideration, the complexity and expected dura-
bility of the intervention, as well as the degree and extent of
forefoot infection and ischemia, will need to be carefully assessed
before embarking on amputation or revascularization. A third
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treatment alternative that the judicious clinician can effectively use
for many such patients (particularly those with only mild or inter-
mittent rest pain and small nonhealing or intermittently healing
and recurring ulcerations) is intensive medical management with
meticulous wound care, small doses of pain medicine, and perhaps
utilization of intermittent compression devices; the ulcer may heal,
albeit slowly, or the patient can live with his or her imperfect, but
still mostly functional limb and remain at home for the remainder
of his or her life. I agree with the authors in this respect: every frail
patient does not require aggressive intervention.
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